Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Clinical trial NCT01827839 · COMPLETED
Trial details
- NCT number
- NCT01827839
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-10
- Primary completion
- 2014-02-10
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.